Skip to main content
Coronavirus in Texas

Texas biotech facility in College Station tapped to mass-produce potential COVID-19 vaccine

The Texas A&M University System Center for Innovation in Advanced Development and Manufacturing has a federal contract to mass-manufacture doses of a candidate COVID-19 vaccine being developed by Novavax.

Graduate research assistant Nicole Johnson researches viral proteins at the McLellan Lab at The University of Texas at Austin on March 11, 2020.

Quality journalism doesn't come free

Yes, I'll donate today